Yes Tom , we did , Anatabloc ..
And this is why I personally don’t trust to much those Health Organization trying “ to help us “
Leronlimab should have EUA given after the critical Covid showed 82% mortality benefit ABOVE any other drug , ( when Leronlimab was in the system ).
And in our CD12 dose should never be cut , for this patients on the ventilators and ECMO , from 4 to 2 .
But again , this is another thing shareholder’s have no influence over .
Hopefully at some point soon we will progress , even with everything around against us !!
All imo
GLTA longs
Bullish